InvestorsHub Logo
icon url

sukus

01/27/22 8:56 AM

#439095 RE: MI Dendream #439077

Thanks MI Dendream. Very nice estimate.

“That creates a delta vs placebo which is about 5x natural history at 5 years which included IDH patients.”
icon url

Chiugray

01/27/22 11:39 AM

#439171 RE: MI Dendream #439077

MiD, Excellent look into the long term survival rate at 5 years.

I especially like this

What are we invested in an ancient pharma with little pipeline and future headwinds or should our multiple valuation look more like a burgeoning biotech with a deep pipeline and novel approaches to disease with high unmet medical need, very, very high unmet need.


Who knows, the DCVax platform may go along the horizontal growth rate by treating one additional cancer at a time. But what if the platform can also grow along the vertical, has exponential potential. Flipper brought up the idea possibility of treating virus infections. We are talking about DCVax making smarter the most powerful treatment in existence and forever, our immune system. There is "no toxicity" so no limits as a potential treatment option. Sorry, this is over my head a bit, but I have to babble out my excitement.